ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BPCR Biopharma Credit Plc

0.878
-0.002 (-0.23%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biopharma Credit Plc LSE:BPCR London Ordinary Share GB00BDGKMY29 ORD USD0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.002 -0.23% 0.878 0.878 0.88 0.882 0.878 0.882 2,145,874 16:35:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 135.74M 108.45M 0.0833 8.50 922.3M

BioPharma Credit PLC Director/PDMR Shareholding (8034A)

01/10/2020 11:00am

UK Regulatory


Biopharma Credit (LSE:BPCR)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Biopharma Credit Charts.

TIDMBPCR

RNS Number : 8034A

BioPharma Credit PLC

01 October 2020

BIOPHARMA CREDIT PLC

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 
 1.   Details of person discharging managerial responsibilities/person 
       closely associated with them 
 a)   Name                      Linda Davey 
     ------------------------  -------------------------------------------- 
 2.   Reason for the notification 
     ---------------------------------------------------------------------- 
 a)   Position / status         Person Closely Associated with Rolf 
                                 Soderstrom (Director of BioPharma Credit 
                                 PLC) 
     ------------------------  -------------------------------------------- 
 b)   Initial notification      Initial notification 
       / amendment 
     ------------------------  -------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------------- 
 a)   Name                      BioPharma Credit PLC 
     ------------------------  -------------------------------------------- 
 b)   LEI                       213800AV55PYXAS7SY24 
     ------------------------  -------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ---------------------------------------------------------------------- 
 a)   Description                 Ordinary Shares of $0.01 each 
       of the financial            GB00BDGKMY29 
       instrument 
       Identification 
       Code 
     --------------------------  ------------------------------------------ 
 b)   Nature of the               Acquisition of Shares 
       transaction 
     --------------------------  ------------------------------------------ 
 c)   Price(s) and                 Price(s)       Volume(s) 
       volume(s)                    GBP0.787344    50,000 
                                                  ---------- 
     --------------------------  ------------------------------------------ 
 d)   Aggregated information      N/A 
       - Aggregated 
       volume 
       - Price 
     --------------------------  ------------------------------------------ 
 e)   Date of the                 30.09.2020 
       transaction 
     --------------------------  ------------------------------------------ 
 f)   Place of the                London Stock Exchange (XLON) 
       transaction 
     --------------------------  ------------------------------------------ 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGCBDGDSGDGGB

(END) Dow Jones Newswires

October 01, 2020 06:00 ET (10:00 GMT)

1 Year Biopharma Credit Chart

1 Year Biopharma Credit Chart

1 Month Biopharma Credit Chart

1 Month Biopharma Credit Chart

Your Recent History

Delayed Upgrade Clock